Replies to post #5090 on AVEO Pharmaceuticals, Inc. (AVEO)

[Biotech Pharmer]

The scam continues with scam artists like Brian Rini weighing in:

Great job @montypal updating TIVO3. Durability of response is interesting for a tki in refractory setting. Tolerability is key in this setting. pic.twitter.com/UCDEN1qGCb

— Brian Rini, MD (@brian_rini) November 16, 2019

What does he know about RCC?

[harry crumb]

They wont get approval! Why would they now? Prior testing failed an the fda doesn’t sit well with that. There were many flaws in the testing, otherwise if tivo was truly so good, the fda would have pushed the process as a breakthrough candidate, that isn’t the case. Its just a matter of time til the collapse of bailys scams comes to reality.